Announcements Trials
Browse Landscape

Phase

Phase NA 14Phase 2 2Phase 1 2Phase 3 1Phase 1/2 1

Status

Unknown 1Enrolling by invitation 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Early-stage Peripheral Non-small Cell Lung Cancer 1Carcinoma, Hepatocellular 1

Interventions

Cisplatin 1041Cyclophosphamide 973Carboplatin 954Radiotherapy 893Bevacizumab 847Gemcitabine 817pembrolizumab 759Paclitaxel 738Docetaxel 734Oxaliplatin 706Capecitabine 649Fluorouracil 564Rituximab 559Nivolumab 506Dexamethasone 487Etoposide 468Doxorubicin 458Irinotecan 442Drug Therapy 402Leucovorin 377Cytarabine 342Cetuximab 340Lenalidomide 326Trastuzumab 323Pemetrexed 315durvalumab 295Filgrastim 287Magnetic Resonance Spectroscopy 278Temozolomide 275Prednisone 274

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × OTHER × Drug Delivery Systems × Clear all
NCT07167459 2025-09-11

Personalized SBRT in Early-Stage Peripheral NSCLC

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Enrolling by invitation
251 enrolled
Thoracic

Early-stage Peripheral Non-small Cell Lung Cancer

NCT05903456 2023-06-15

Icaritin Soft Capsule Combined With Lenvatinib and TACE for the Treatment of Hepatocellular Carcinoma

Zhejiang Cancer Hospital

Phase 2 Unknown
20 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡